Assessments at baseline and day 14 after etanercept treatment (n=10)52
| Parameter | Baseline | Week 24 | p Value |
|---|---|---|---|
| Values are the median. | |||
| Global disease activity assessments | |||
| Patient (0–100) | 70 | 3 | 0.005 |
| Physician (0–100) | 60.5 | 3 | 0.005 |
| Axial assessments | |||
| BASDAI (0–10) | 6.25 | 1.3 | 0.005 |
| BASFAI (0–10) | 7.05 | 4.35 | 0.008 |
| Spinal pain (day; 0–100) | 63.5 | 10 | 0.008 |
| Spinal pain (night; 0–100) | 71.5 | 4 | 0.008 |
| Peripheral assessments | |||
| Early morning stiffness (min) | 120 | 2.5 | 0.008 |
| Tender joint count (0–68) | 6 | 0 | 0.046 |
| Swollen joint count (0–66) | 0.5 | 0 | 0.043 |
| Enthesopathy (0–100) | 62 | 3 | 0.008 |
| ASQoL (0–18) | 14 | 3 | 0.005 |